vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Principal Financial Group (PFG). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $750.8M, roughly 1.1× Principal Financial Group). Acadia Healthcare Company, Inc. runs the higher net margin — 0.5% vs 0.3%, a 0.3% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 4.0%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -58.3%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Principal Financial GroupPFGEarnings & Financial Report
Principal Financial Group, Inc. (PFG) is an American global financial investment management and insurance company headquartered in Des Moines, Iowa, United States.
ACHC vs PFG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $750.8M |
| Net Profit | $4.5M | $1.9M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 0.5% | 0.3% |
| Revenue YoY | 7.5% | 4.0% |
| Net Profit YoY | -50.8% | 783.0% |
| EPS (diluted) | $0.05 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $750.8M | ||
| Q4 25 | $821.5M | $4.6B | ||
| Q3 25 | $851.6M | $3.7B | ||
| Q2 25 | $869.2M | $3.7B | ||
| Q1 25 | $770.5M | $3.7B | ||
| Q4 24 | $774.2M | $4.8B | ||
| Q3 24 | $815.6M | $3.0B | ||
| Q2 24 | $796.0M | $4.3B |
| Q1 26 | $4.5M | $1.9M | ||
| Q4 25 | $-1.2B | $517.0M | ||
| Q3 25 | $36.2M | $213.8M | ||
| Q2 25 | $30.1M | $406.2M | ||
| Q1 25 | $8.4M | $48.1M | ||
| Q4 24 | $32.6M | $905.4M | ||
| Q3 24 | $68.1M | $-220.0M | ||
| Q2 24 | $78.5M | $353.1M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | — |
| Q1 26 | 0.5% | 0.3% | ||
| Q4 25 | -143.3% | 11.3% | ||
| Q3 25 | 4.3% | 5.8% | ||
| Q2 25 | 3.5% | 11.1% | ||
| Q1 25 | 1.1% | 1.3% | ||
| Q4 24 | 4.2% | 19.1% | ||
| Q3 24 | 8.4% | -7.3% | ||
| Q2 24 | 9.9% | 8.2% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $2.30 | ||
| Q3 25 | $0.40 | $0.95 | ||
| Q2 25 | $0.33 | $1.79 | ||
| Q1 25 | $0.09 | $0.21 | ||
| Q4 24 | $0.36 | $3.92 | ||
| Q3 24 | $0.74 | $-0.95 | ||
| Q2 24 | $0.85 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | — |
| Total Assets | $5.5B | — |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $4.4B | ||
| Q3 25 | $118.7M | $5.1B | ||
| Q2 25 | $131.4M | $3.7B | ||
| Q1 25 | $91.2M | $3.9B | ||
| Q4 24 | $76.3M | $4.2B | ||
| Q3 24 | $82.1M | $6.2B | ||
| Q2 24 | $77.2M | $4.8B |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $3.9B | ||
| Q3 25 | $2.3B | $3.9B | ||
| Q2 25 | $2.3B | $3.9B | ||
| Q1 25 | $2.2B | $4.3B | ||
| Q4 24 | $2.0B | $4.0B | ||
| Q3 24 | $1.9B | $3.9B | ||
| Q2 24 | $1.8B | $3.9B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $11.9B | ||
| Q3 25 | $3.1B | $11.7B | ||
| Q2 25 | $3.1B | $11.4B | ||
| Q1 25 | $3.0B | $11.2B | ||
| Q4 24 | $3.1B | $11.1B | ||
| Q3 24 | $3.0B | $11.2B | ||
| Q2 24 | $3.0B | $11.0B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $341.4B | ||
| Q3 25 | $6.4B | $334.5B | ||
| Q2 25 | $6.3B | $323.1B | ||
| Q1 25 | $6.1B | $313.0B | ||
| Q4 24 | $6.0B | $313.7B | ||
| Q3 24 | $5.9B | $322.9B | ||
| Q2 24 | $5.7B | $308.8B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.33× | ||
| Q3 25 | 0.74× | 0.34× | ||
| Q2 25 | 0.74× | 0.34× | ||
| Q1 25 | 0.72× | 0.39× | ||
| Q4 24 | 0.64× | 0.36× | ||
| Q3 24 | 0.62× | 0.35× | ||
| Q2 24 | 0.62× | 0.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $1.7B | ||
| Q3 25 | $73.2M | $1.0B | ||
| Q2 25 | $133.5M | $811.9M | ||
| Q1 25 | $11.5M | $977.3M | ||
| Q4 24 | $116.7M | $1.5B | ||
| Q3 24 | $163.1M | $1.1B | ||
| Q2 24 | $171.1M | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.37× | ||
| Q3 25 | 2.02× | 4.70× | ||
| Q2 25 | 4.43× | 2.00× | ||
| Q1 25 | 1.37× | 20.32× | ||
| Q4 24 | 3.58× | 1.61× | ||
| Q3 24 | 2.39× | — | ||
| Q2 24 | 2.18× | 4.05× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
PFG
Segment breakdown not available.
